MeSH D006323 - heart arrest
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Epinephrine | Epinephrine |  | 2018-08-16 |  |  |
| Mylan | Atropine, Diphenoxylate | Diphenoxylate Atropine |  | 1982-01-01 |  |  |
| Atropine, EDROPHONIUM | Enlon |  | 1991-11-06 |  |  | |
| Epinephrine | Epi | 2025-09-11 | 1987-12-22 |  |  | |
| Isoproterenol | Isoproterenol |  | 2022-09-06 |  |  | |
| Armstrong Pharmaceuticals | Epinephrine | Epinephrine |  | 1984-05-23 |  |  |
| Epinephrine | Primatene Mist | 2026-01-26 | 2018-11-07 |  |  | |
| Cipla | Isoproterenol | Isoproterenol |  | 2018-06-12 |  |  |
| AbbVie | Atropine | Atropine |  | 1987-01-30 |  |  |
| Atropine, Meperidine | Atropine Demerol |  | 1982-11-26 |  |  | |
| Isoproterenol | Norisodrine |  | 1982-01-01 |  |  | |
| AstraZeneca | Prilocaine, Epinephrine | Citanest |  | 1982-01-01 |  |  |
| Epinephrine, Etidocaine | Duranest |  | 1982-01-01 |  |  | |
| Lidocaine, Epinephrine | Xylocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| Sanofi | Isoproterenol | Isuprel |  | 1982-01-01 |  |  |
| Wyeth | Epinephrine | Bronitin Mist |  | 1982-01-01 |  |  |
| Atropine, Meperidine | Meperidine Atropine |  | 1982-01-01 |  |  | |
| Sterling Winthrop | Epinephrine | Bronkaid Mist |  | 1982-01-01 |  |  |
| 3M | Phenylephrine, Isoproterenol | Duo-medihaler |  | 1982-01-01 |  |  |
| Isoproterenol | Isoproterenol |  | 1982-01-01 |  |  | |
| Epinephrine | Medihaler-epi |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
70%14/20
Phase 2
63%15/24
Phase 3
18%6/33
Approved: 3Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use